#CancerTherapy
LightNews LightNews
sigtrans-sttt.bsky.social
A bio-barrier-adaptable #Biomimetic #Nanoplatform, MSF@CCM, exhibits enhanced #TumorAccumulation & #ImmuneEvasion along with amplified ultrasound-mediated intratumoral penetration, highlighting it as a promising modality for #CancerTherapy.

#OpenAccess: doi.org/10.1038/s413...
December 26, 2025 at 10:00 AM
int-pharmacy.bsky.social
Can sound waves boost cancer therapy? Study finds sonodynamic therapy with DOX hydrogel enhances tumor inhibition. #CancerTherapy #SonodynamicTherapy
www.rimpacts.com/rd/p?c=10060... 📄DOI: doi.org/10.1016/j.ij...
Synergistic Effects of Doxorubicin Loaded Silk Fibroin Nanoparticles and Cu-Tio2 Nanoparticles for Local Chemo-Sonodynamic Therapy Against Breast Cancer
Can sound waves boost cancer therapy? Study finds sonodynamic therapy with DOX hydrogel enhances tumor inhibition. #CancerTherapy #SonodynamicTherapy
www.rimpacts.com
December 24, 2025 at 9:41 AM
yuvip.bsky.social
🇮🇳🩸 India Leukemia Therapeutics Market trends 👉 www.marketresearchfuture.com/reports/indi... #Leukemia #CancerTherapy #IndiaHealthcare
India Leukemia Therapeutics Market Size, Growth, Report 2035
India Leukemia Therapeutics Market 2025, to reach USD 2.87 Billion, at a 4.83% CAGR by growing size, share, top company, research analysis, segments, trends and forecast to 2035
www.marketresearchfuture.com
December 23, 2025 at 9:40 AM
inovineconferences.bsky.social
🌍 Advancing Cancer Research & Care on a Global Stage
Join the 12th Global Summit on Cancer Science and Therapy (GSCST 2026)
📅August 03–04, 2026
📍Zurich, Switzerland
🔗 Register now: lnkd.in/dPpBdBht

#cancerscience #cancertherapy #oncologyconference #cancerresearch
December 19, 2025 at 12:48 PM
medchemexpress.bsky.social
🔥Hot Off the Press | New study highlights #DLAT’s key role in chemotherapy resistance via acetylation & metabolic rewiring. #DMp39, a novel decoy #peptide, shows promise as a targeted #mitochondrial therapy—optimization could pave the way for clinical use.
#CancerTherapy
December 18, 2025 at 3:32 AM
sigtrans-sttt.bsky.social
Targeting cytokine and chemokine pathways offers powerful strategies to reshape tumor immunity and improve cancer treatment outcomes.
#Cytokines #Chemokines #ImmuneSignaling #CancerTherapy
www.nature.com/articles/s41...
December 16, 2025 at 1:35 PM
aspetjournals.bsky.social
EGFR drives many cancers, but resistance remains a challenge. This review decodes EGFR biology and emerging strategies to overcome therapy resistance. #PharmRev #cancertherapy #science 🧪
https://ow.ly/IiMg50XHqHK
December 15, 2025 at 2:01 PM
neuralgrndstate.bsky.social
Cancer results from cellular property change, loss of original cell identity&acquir. of neural stemness. It should be understood by gene symbols together with cellular property but not solely by gene symbols.
#pancreaticcancer #PDAC #tumor #genetics #cancertherapy
@genesdev.bsky.social
December 13, 2025 at 8:16 AM
vanjohn10.bsky.social
GeoVax' #CEO David A. Dodd looks at the Modified Vaccinia Ankara (MVA) platform & how $GOVX is adapting it to be used in developing and developed regions alike.
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #GeneTherapy #HeadAndNeckCancer #SolidTumor #CancerResearch #Oncology
December 12, 2025 at 8:54 PM
genesdev.bsky.social
⏪ G&D RECAP ⏪

🗓️ January 2025
REVIEW: Genetics and biology of pancreatic ductal adenocarcinoma
By Ying et al. and Ronald DePinho
➡️ https://genesdev.cshlp.org/content/39/1-2/36.full

#pancreaticcancer #PDAC #tumor #genetics #tumormicroenvironment #cancertherapy
December 12, 2025 at 6:52 PM
oligo-nucleotide.bsky.social
Lipid nanoparticles are transforming precision cancer therapy with smarter, targeted delivery.
Join us at OTDC, May 25–26, 2026 in Rome, Italy, to explore next-gen oligonucleotide innovation.
🔗 oligo-nucleotide.com
#LNP #Nanomedicine #OTDC2026 #CancerTherapy#Nanocarriers #SmartDrugDelivery
December 12, 2025 at 4:45 AM
medtums.bsky.social
Can bacteria fight cancer? Study finds bacterial ghosts enhance NP delivery for therapy. #CancerTherapy #BacterialDelivery
www.rimpacts.com/rd/p?c=10093... 📄DOI: doi.org/10.1080/1061...
The Potential Use of Bacteria and Their Derivatives As Delivery Systems for Nanoparticles in the Treatment of Cancer
Can bacteria fight cancer? Study finds bacterial ghosts enhance NP delivery for therapy. #CancerTherapy #BacterialDelivery
www.rimpacts.com
December 10, 2025 at 4:32 AM
oncoassist.bsky.social
🔗 Read more: bit.ly/ONCOnews05D-2

#ONCOnews #OncoAlert #OncEd #OncologyNews #CancerTherapy #ClinicalTrials #LymphomaTreatment
December 5, 2025 at 2:30 PM
vanjohn10.bsky.social
GeoVax CEO David Dodd compares the US and China's #biotech industries & shares steps to take to maintain our leading position.
$GOVX
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #GeneTherapy #HeadAndNeckCancer #SolidTumor #CancerResearch
December 2, 2025 at 2:33 PM
healthcaretoday.bsky.social
Cambridge-based T-Therapeutics, a biotechnology company developing T cell receptor therapeutics for cancer and autoimmune disease, has completed the expansion of its Series A funding to £69.2 million.

healthcaretoday.com/article/t-th...

#healthcare #innovation #biotechnology #CancerTherapy
T-Therapeutics closes Series A funding
The closure of the Cambridge-based biotech company’s round of funding at $91 million will allow it to develop its pipeline of drugs.
healthcaretoday.com
November 27, 2025 at 9:10 AM
yoshitakahoshi.bsky.social
Roche’s Lunsumio SC Granted Conditional EU Approval for Relapsed/Refractory Follicular Lymphoma

🔗 Full article: stellanews.life/technology_c...

#Roche #Lunsumio #Mosunetuzumab #FollicularLymphoma #Hematology #CancerTherapy #Subcutaneous #OncologyNews #Biopharma
RocheのLunsumio皮下注製剤、再発・難治性濾胞性リンパ腫に対しEUで条件付き承認 外来投与が約1分に短縮 | STELLANEWS.LIFE
Rocheは、再発または難治性濾胞性リンパ腫に対するLunsumio（mosunetuzumab）皮下注製剤が欧州委員会より条件付き販売承認を取得したと発表。投与時間の短縮や有効性、安全性が第1／2相試験で確認され、外来投与の利便性向上に寄与。
stellanews.life
November 24, 2025 at 10:10 PM
yoshitakahoshi.bsky.social
GSK partners with LTZ Therapeutics to develop up to four novel myeloid cell engagers (MCEs) for cancer treatment.

🔗 Full article: stellanews.life/technology_c...

#GSK #LTZTherapeutics #MyeloidCellEngager #ImmunoOncology #CancerTherapy #Biotech #Partnership #OncologyResearch
GSKとLTZ、マイロイド細胞エンゲージャーのがん治療開発で提携 初の前臨床候補を含む最大4品目を視野に | STELLANEWS.LIFE
GSKは、免疫療法スタートアップのLTZ Therapeuticsと、血液がんおよび固形がんを対象としたマイロイド細胞エンゲージャー（MCE）4品目の開発で提携。前臨床段階の新規免疫エンゲージャープラットフォームを活用し、安全性と治療効果の両立を狙う。契約には最大5,000万ドルの一時金と開発後のマイルストーンが含まれる。
stellanews.life
November 24, 2025 at 9:43 PM
genesndiseases.bsky.social
This latest review examines the pivotal role of #DendriticCellVaccines in #CancerTherapy and highlights ongoing efforts to enhance their effectiveness through combination strategies and advanced preparation techniques. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...
November 22, 2025 at 4:15 PM
icelabumu.bsky.social
Johan Henriksson (IceLab affiliate) has secured SEK 10 M to build a massive single-cell database to accelerate safer and more affordable CAR T-cell therapies for cancer. Wishing the team great success! www.umu.se/en/news/fast... #singlecell #cancertherapy #umeåresearch
Faster and safer development of CAR T cells against cancer
Ten million for innovative technology in cancer research.
www.umu.se
November 13, 2025 at 1:03 PM
vibtrainconf.bsky.social
The fight against cancer progression begins with knowledge; understanding metastasis is key to shaping outcomes for millions, and the latest research is explored at #THPT25.

Register before the final deadline on 26 November: vibbio.tech/47mZsxa

#tumorbiology #cancertherapy #VIBConf
November 13, 2025 at 12:15 PM
genesndiseases.bsky.social
This review examines the regulatory roles of #Ubiquitination and #Deubiquitination in the #TumorMicroenvironment and discusses the potential of targeting ubiquity-related #Enzymes for #CancerTherapy. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...
November 11, 2025 at 12:37 PM
mknanomedicine.bsky.social
Want to know how to grow patient-derived tumours?? Read our article #chidhoodcancer #tumouroids #cancertherapy #cancermodels

High-throughput 3D engineered paediatric tumour models for precision medicine | Molecular Systems Biology www.embopress.org/doi/full/10....
High-throughput 3D engineered paediatric tumour models for precision medicine | Molecular Systems Biology
imageimageHigh throughput 3D bioprinting platform incorporating engineered tissue-mimic hydrogel enables rapid generation of patient specific paediatric cancer models, facilitating personalised drug s...
www.embopress.org
November 10, 2025 at 4:43 AM
genesndiseases.bsky.social
This review highlights the role of #LKB1 in #Tumorigenesis and its therapeutic relevance in #Oncology, offering new insights into targeted #CancerTherapy. @westernu.bsky.social #medsky

#OpenAccess: www.sciencedirect.com/science/arti...
November 8, 2025 at 3:53 PM
sigtrans-sttt.bsky.social
This review highlights lactate’s role in shaping the #TumorMicroEnvironment and discusses therapeutic strategies targeting #LactateDehydrogenase and MCT to exploit #LactateMetabolism as a promising strategy to enhance #CancerTherapy effectiveness.

#STTT: doi.org/10.1038/s413...
November 8, 2025 at 4:30 AM
genesdev.bsky.social
REVIEW: Multifaceted role of the vitamin B6 pathway in cancer: metabolism, immune interaction, and temporal and spatial regulation
By Mishra et al. and Lingbo Zhang
➡️ https://genesdev.cshlp.org/content/39/21-22/1271.abstract

#cancer #metabolism #vitamin #cancertherapy #cancermetabolism #immune
November 7, 2025 at 7:01 PM